The Food and Drug Administration has granted approval for the first flu vaccine that uses mRNA technology, according to Moderna. This development opens a path for a new vaccination option aimed at individuals aged 50 and above, targeting protection against influenza.
Moderna revealed that the newly approved vaccine will likely become available at select retailers in the upcoming weeks. This announcement follows discussions and controversies, including skepticism from Robert F. Kennedy Jr. regarding mRNA technology.
A photograph from 2024 shows a researcher working at Moderna’s headquarters in Cambridge, Massachusetts, illustrating the ongoing efforts in mRNA vaccine development.
U.S. Monitors Russian Plague Scare 
Guide to Choosing the Best Probiotic Powder for Gut Health 
2026 Nobel Prize in Physiology or Medicine Awarded for Optogenetics Research 
Trump’s Daily Aspirin Habit and Its Implications 
Grudges and Forgiveness: The Impact on Mental Health 
Crackdown on Fraudulent Obamacare Enrollments